Upstream Bio

Upstream Bio is a biotech company aiming to develop therapies that get to the source of inflammation. 

The Top Line
Podcast

What can we learn from 2024’s biotech IPOs?

This week on "The Top Line," we explore the biotech IPO market rebound and ask: Is the momentum here to stay?
Ayla Ellison , James Waldron Dec 6, 2024 8:44am
Photo of Wall Street street sign with american flags in the background

Upstream swells IPO to $255M as it lists alongside CAMP4

Oct 11, 2024 5:18am
IPO initial public offering wall street

CAMP4 is latest to eye IPO, while Upstream spells out $182M plan

Oct 7, 2024 8:44am
salmon river fish jump upstream katmai alaska

Inflammation-focused Upstream to join trickle of biotech IPOs

Sep 19, 2024 4:50am
parachute chutes

Lonza lands new CEO—Chutes & Ladders

Apr 5, 2024 8:30am
2022 money

Biotech's top money raisers: 2022

Apr 11, 2023 9:19am